Compulsory License Battle Moves To Indian Court
Heating up the controversy over compulsory licensing, the High Court of Delhi reportedly is set to consider whether Indian generics manufacturer Natco Pharma should be allowed to override patents on cancer...To view the full article, register now.
Already a subscriber? Click here to view full article